Baird Medical Investment Holdings Ltd (BDMD)
NASDAQ: BDMDHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BDMD stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.07M
- Forward P/E
- 0.64
- EPS (TTM)
- -$0.55
- Dividend yield
- None
- 52-week range
- 0.073 – 3.70
- Day range
- 0.086 – 0.0988
- Volume / Avg
- 1.60M / 16.31M
- Beta
- —
- Shares outstanding
- 56.52M
52-week range
BDMD stock today
On Nov 20, BDMD ended the session at $0.0897, shedding $0.0133 (12.91%), versus the S&P 500's 3.70% decline. Trading was light, with 1.60M shares changing hands, about 10% of the average daily volume. Shares are 97.6% below their 52-week high of $3.70, set on Mar 2, 2026 and 22.9% above the 52-week low of $0.073, near the bottom of the past year's range.
BDMD is down 93.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 93.6%. Baird Medical Investment has posted a net loss over the last twelve months (EPS of -$0.55), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Baird Medical Investment
Company profileBaird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Ms. Haimei Wu
- Headquarters
- Guangzhou
- Employees
- 146
- Website
- bairdmed.com
Financial highlights
Full financialsIn fiscal 2025, Baird Medical Investment generated $22.5 million in revenue, down 39.2% from fiscal 2024, its first annual decline since 2023. Baird Medical Investment reported a net loss of $27.3 million, compared with net income of $12.5 million a year earlier. Gross margin was 83.8% (down from 88.2%) and operating margin -113.7%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Revenue | $22.54M | $37.04M | $31.46M | $35.09M |
| Growth | -39.15% | +17.74% | -10.35% | — |
| Net income | $-27.28M | $12.45M | $10.55M | $12.77M |
| EPS (diluted) | $-0.98 | $0.57 | $0.51 | $0.49 |
Analyst forecast
ForecastConsensus
none
Avg. price target
$4.00+4359.31%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
BDMD news
All BDMD news- Baird Medical Enters South Korea Market through Strategic Distribution Partnership with ALLIS MEDGlobeNewswire
- Baird Partner Alpmed Seeks FDA And EU Clearance For IRE System In Cancer; Stock Plunges 44%NasdaqBDMD, HEI.A
- Baird Medical Issues Statement Regarding Recent Share Price VolatilityGlobeNewswire
- Weekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial WinNasdaqABBV, ABT, ACHV, ALVO
- Baird Gets Vietnam Device Registrations, Preliminary Approval In Egypt For Ablation TechnologyNasdaqBDMD, ET
- Baird Medical Announces Regulatory Milestones in Vietnam and Egypt, Expanding International Reach of Microwave Ablation TechnologyGlobeNewswire
Baird Medical Investment peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ICUSeaStar Medical Holding Corporation | 0.935 | -10.95% | $4.97M | vs BDMD |
| WOKWORK Medical Technology Group LTD Class A | 1.10 | -5.13% | $4.90M | vs BDMD |
| INBSIntelligent Bio Solutions Inc. | 1.39 | -7.95% | $4.61M | vs BDMD |
| ICCMIceCure Medical Ltd. | 0.8006 | -19.71% | $4.45M | vs BDMD |
| NMTCNeuroOne Medical Technologies Corporation | 0.6521 | -3.38% | $5.94M | vs BDMD |
| CNSYCerenome Inc. | 0.6301 | -10.29% | $6.16M | vs BDMD |
| ARAYAccuray Incorporated | 2.08 | -2.12% | $6.22M | vs BDMD |
| SNOASonoma Pharmaceuticals Inc. | 0.722 | -10.83% | $3.65M | vs BDMD |
Indexes, lists and sector
Baird Medical Investment stock FAQ
What is Baird Medical Investment's stock price today?
BDMD last traded at $0.0897 as of Nov 20, 4:00 PM EST, down 12.91% on the day. Prices are delayed at least 15 minutes.
Who is Baird Medical Investment's CEO?
Ms. Haimei Wu is the chief executive officer of Baird Medical Investment Holdings Ltd, which has about 146 employees.
What is the BDMD 52-week high?
The 52-week high for BDMD is $3.70 and the 52-week low is $0.073. The stock is currently 97.6% below its high.